A. Bertolini

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10

Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study

Roberto Buzzoni, Sara Pusceddu, Emilio Bajetta et al. · Annals of Oncology · 2014 · 68 citations · Full text

Medicine, Oncology, Chemotherapy +10

CNS response to osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFR-TKI sensitising mutation (EGFRm)-positive advanced non-small cell lung cancer (NSCLC): Data from the FLAURA study

Johan Vansteenkiste, Thanyanan Reungwetwattana, Kazuhiko Nakagawa et al. · Annals of Oncology · 2017 · 33 citations

Medicine, Oncology, Pharmacotherapy +15

Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis

Daniele Fagnani, Riccardo Franchi, Camillo Porta et al. · Annals of Oncology · 2006 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Caerulein and cholecystokinin reverse experimental hemorrhagic shock

A. Bertolini, Salvatore Guarini, W Ferrari et al. · Neuropeptides · 1986 · 21 citations · Full text

Medicine, Pathology, Pathophysiology +4